Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's Disease-like symptoms in rats: Protective effect of licofelone

96Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND AND PURPOSE Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by a degeneration of striatal neurons. The possible role of COX and lipoxygenase (LOX) pathways has been well-documented in the pathology of several neurodegenerative disorders including HD. Licofelone is a competitive inhibitor of COX-1- and COX-2 and 5-LOX isoenzymes. Therefore, the present study was designed to investigate possible neuroinflammatory and apoptotic mechanisms in the neuroprotective effect of licofelone against 3-nitropropionic acid (3-NP)-induced HD-like symptoms in rats. EXPERIMENTAL APPROACH Rats were administered 3-NP (10 mg·kg-1day-1, i.p.) for 14 days. Licofelone (2.5, 5 and 10 mg·kg-1, p.o.) was given once a day, 1 h before 3-NP treatment for 14 days. Body weight and behavioural parameters (locomotor and rotarod activity) were assessed on the 1st, 5th, 10th and 15th day post-3-NP administration. Malondialdehyde, nitrite concentration, endogenous antioxidant enzymes (superoxide dismutase and catalase levels), mitochondrial enzyme complexes, pro-inflammatory compounds (TNF-α, IL-6, NF-κB), PGs (PGE2 and PGF2α) and caspase-3 activity were measured on day 15 in the striatum. KEY RESULTS Systemic 3-NP treatment significantly reduced body weight, locomotor activity, oxidative defence, mitochondrial enzyme complex activities and increased TNF-α, IL-6, caspase-3 activity, NF-κB and PGE2 and PGF2α levels in the striatum. Licofelone (2.5, 5 and 10 mg·kg-1) significantly attenuated the impairment in behavioural, biochemical and mitochondrial, pro-inflammatory and pro-apoptotic markers as compared with vehicle-treated group. CONCLUSIONS AND IMPLICATIONS The results demonstrate the involvement of pro-inflammatory compounds and the apoptotic cascade in the neuroprotective effect of licofelone against 3-NP-induced neurotoxicity. © 2011 The British Pharmacological Society.

Cite

CITATION STYLE

APA

Kumar, P., Kalonia, H., & Kumar, A. (2011). Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington’s Disease-like symptoms in rats: Protective effect of licofelone. British Journal of Pharmacology, 164(2 B), 644–654. https://doi.org/10.1111/j.1476-5381.2011.01418.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free